On 8 August 2017
GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 8 August 2017, to, inter-alia, consider and take on record the unaudited Financial Results for the quarter ended 30 June 2017 with Limited Review by Auditors.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
